1. Home
  2. FGEN vs HTCO Comparison

FGEN vs HTCO Comparison

Compare FGEN & HTCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FGEN
  • HTCO
  • Stock Information
  • Founded
  • FGEN 1993
  • HTCO 2022
  • Country
  • FGEN United States
  • HTCO Singapore
  • Employees
  • FGEN N/A
  • HTCO N/A
  • Industry
  • FGEN Biotechnology: Pharmaceutical Preparations
  • HTCO
  • Sector
  • FGEN Health Care
  • HTCO
  • Exchange
  • FGEN Nasdaq
  • HTCO NYSE
  • Market Cap
  • FGEN 33.5M
  • HTCO 38.7M
  • IPO Year
  • FGEN 2014
  • HTCO N/A
  • Fundamental
  • Price
  • FGEN $5.61
  • HTCO $0.21
  • Analyst Decision
  • FGEN Strong Buy
  • HTCO
  • Analyst Count
  • FGEN 1
  • HTCO 0
  • Target Price
  • FGEN $250.00
  • HTCO N/A
  • AVG Volume (30 Days)
  • FGEN 60.2K
  • HTCO 2.0M
  • Earning Date
  • FGEN 08-05-2025
  • HTCO 01-01-0001
  • Dividend Yield
  • FGEN N/A
  • HTCO N/A
  • EPS Growth
  • FGEN N/A
  • HTCO N/A
  • EPS
  • FGEN N/A
  • HTCO N/A
  • Revenue
  • FGEN $6,996,000.00
  • HTCO $108,176,683.00
  • Revenue This Year
  • FGEN N/A
  • HTCO N/A
  • Revenue Next Year
  • FGEN N/A
  • HTCO N/A
  • P/E Ratio
  • FGEN N/A
  • HTCO N/A
  • Revenue Growth
  • FGEN N/A
  • HTCO 13.56
  • 52 Week Low
  • FGEN $4.50
  • HTCO $0.18
  • 52 Week High
  • FGEN $38.25
  • HTCO $4.50
  • Technical
  • Relative Strength Index (RSI)
  • FGEN 39.07
  • HTCO N/A
  • Support Level
  • FGEN $4.85
  • HTCO N/A
  • Resistance Level
  • FGEN $5.77
  • HTCO N/A
  • Average True Range (ATR)
  • FGEN 0.57
  • HTCO 0.00
  • MACD
  • FGEN -0.02
  • HTCO 0.00
  • Stochastic Oscillator
  • FGEN 31.67
  • HTCO 0.00

About FGEN FibroGen Inc

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.

About HTCO CARAVELLE INTERNATIONAL GROUP

High-Trend International Group formerly Caravelle International Group is an international operator of ocean transportation services. It is engaged in the seaborne transportation service under voyage contracts as well as vessel service for and on behalf of ship owners. The company has two operating segments namely, ocean transport and Heating business. The company derives the majority of its revenue from the Ocean transportation business. The company derives freight revenue from voyage contracts and provides vessel service. Majority of revenue is from providing shipping services for customers in Asia, principally in Singapore, Dubai, Korea, Japan, and India.

Share on Social Networks: